Current Ratio of ALPINE IMMUNE SCIENCES, INC. from 31 Mar 2016 to 31 Mar 2024
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
ALPINE IMMUNE SCIENCES, INC. quarterly Current Ratio in x history and change rate from 31 Mar 2016 to 31 Mar 2024.
- ALPINE IMMUNE SCIENCES, INC. Current Ratio for the quarter ending 31 Mar 2024 was 5.81x, a 65% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
ALPINE IMMUNE SCIENCES, INC. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q1 2024 | 5.81x | +2.3x | +65% | 31 Mar 2024 |
| Q4 2023 | 4.57x | +1.29x | +40% | 31 Dec 2023 |
| Q3 2023 | 3.83x | +0.88x | +30% | 30 Sep 2023 |
| Q2 2023 | 3.8x | +1.06x | +39% | 30 Jun 2023 |
| Q1 2023 | 3.52x | +0.88x | +33% | 31 Mar 2023 |
| Q4 2022 | 3.28x | +0.68x | +26% | 31 Dec 2022 |
| Q3 2022 | 2.95x | +0.41x | +16% | 30 Sep 2022 |
| Q2 2022 | 2.74x | +0.03x | +0.95% | 30 Jun 2022 |
| Q1 2022 | 2.64x | -0.33x | -11% | 31 Mar 2022 |
| Q4 2021 | 2.6x | -0.84x | -24% | 31 Dec 2021 |
| Q3 2021 | 2.54x | -1.49x | -37% | 30 Sep 2021 |
| Q2 2021 | 2.71x | -1.32x | -33% | 30 Jun 2021 |
| Q1 2021 | 2.97x | -1.78x | -37% | 31 Mar 2021 |
| Q4 2020 | 3.44x | -1.52x | -31% | 31 Dec 2020 |
| Q3 2020 | 4.04x | -1.24x | -24% | 30 Sep 2020 |
| Q2 2020 | 4.03x | -2.53x | -39% | 30 Jun 2020 |
| Q1 2020 | 4.75x | -4.54x | -49% | 31 Mar 2020 |
| Q4 2019 | 4.96x | -7.52x | -60% | 31 Dec 2019 |
| Q3 2019 | 5.28x | -14.26x | -73% | 30 Sep 2019 |
| Q2 2019 | 6.56x | -22.64x | -78% | 30 Jun 2019 |
| Q1 2019 | 9.29x | -17.52x | -65% | 31 Mar 2019 |
| Q4 2018 | 12.48x | -10.31x | -45% | 31 Dec 2018 |
| Q3 2018 | 19.54x | +3.34x | +21% | 30 Sep 2018 |
| Q2 2018 | 29.2x | +17.11x | +142% | 30 Jun 2018 |
| Q1 2018 | 26.81x | +14.9x | +125% | 31 Mar 2018 |
| Q4 2017 | 22.79x | +9.87x | +76% | 31 Dec 2017 |
| Q3 2017 | 16.21x | +0.81x | +5.2% | 30 Sep 2017 |
| Q2 2017 | 12.09x | -5.3x | -30% | 30 Jun 2017 |
| Q1 2017 | 11.91x | -6.63x | -36% | 31 Mar 2017 |
| Q4 2016 | 12.92x | 31 Dec 2016 | ||
| Q3 2016 | 15.4x | 30 Sep 2016 | ||
| Q2 2016 | 17.39x | 30 Jun 2016 | ||
| Q1 2016 | 18.54x | 31 Mar 2016 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.